Twin Securities, Inc. reported 6 positions worth $32.58M for the quarter ended Jun 30, 2026, up 54.7% on the prior quarter. It opened 3 new positions, added to 1, trimmed 1 and exited 5. Its largest holding is Roku, Inc at 44.8% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
| Holding | Change | Change % | Trade Value | Weight |
|---|---|---|---|---|
| ACLX GILEAD SCIENCES INC- CVR CONTINGENT VALUE RIGHT | -54.0K | -100.0% | $6.20M | Exited |
| RVMD Revolution Medicines, Inc. | -38.6K | -100.0% | $3.75M | Exited |
| TTWO Take Two Interactive Software Inc | -6,500 | -100.0% | $1.28M | Exited |
| RNA Atrium Therapeutics, Inc. | -23.4K | -46.9% | $314.68K | 1.09% |
| MANU Manchester United plc | -14.9K | -100.0% | $250.95K | Exited |
| SGRY Surgery Partners, Inc. | -10.0K | -100.0% | $119.50K | Exited |
| Holding | Shares Sold | Trade Value | Prior Weight |
|---|---|---|---|
| ACLX GILEAD SCIENCES INC- CVR CONTINGENT VALUE RIGHT | -54.0K | $6.20M | 29.42% |
| RVMD Revolution Medicines, Inc. | -38.6K | $3.75M | 17.82% |
| TTWO Take Two Interactive Software Inc | -6,500 | $1.28M | 6.09% |
| MANU Manchester United plc | -14.9K | $250.95K | 1.19% |
| SGRY Surgery Partners, Inc. | -10.0K | $119.50K | 0.567% |
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | ROKU Roku, Inc | Technology | 105.7K | $14.60M | 44.8% | +105.7K | – | New | 0.08% |
| 2 | KVUE Kenvue Inc. | Consumer Staples | 755.0K | $14.43M | 44.28% | +274.5K | +57.1% | Added | 0.04% |
| 3 | OGN Organon & Co. | Healthcare | 175.1K | $2.37M | 7.28% | +175.1K | – | New | 0.07% |
| 4 | TIC TIC Solutions, Inc. | Industrials | 77.3K | $625.67K | 1.92% | 0 | 0.0% | Unchanged | 0.04% |
| 5 | RNA Atrium Therapeutics, Inc. | Healthcare | 26.5K | $356.65K | 1.09% | -23.4K | -46.9% | Reduced | 0.16% |
| 6 | NSC Norfolk Southern Corp | Industrials | 652 | $205.11K | 0.63% | +652 | – | New | 0% |
Tip. Select a row to see that position’s full history at Twin Securities.
As of its Q2 2026 13F filing, Twin Securities, Inc.’s five largest positions were Roku, Inc (ROKU) at 44.8%, Kenvue Inc. (KVUE) at 44.3%, Organon & Co. (OGN) at 7.3%, TIC Solutions, Inc. (TIC) at 1.9%, Atrium Therapeutics, Inc. (RNA) at 1.1% of the reported portfolio.
Twin Securities, Inc. reported a 13F portfolio worth $32.58M across 6 positions for Q2 2026. That is up 54.7% from the previous quarter.
Its largest purchases by value were Roku, Inc ($14.60M), Kenvue Inc. ($5.24M), Organon & Co. ($2.37M). It opened 3 new positions.
Its largest sales by value were GILEAD SCIENCES INC- CVR CONTINGENT VALUE RIGHT ($6.20M), Revolution Medicines, Inc. ($3.75M), Take Two Interactive Software Inc ($1.28M). It exited 5 positions entirely.
From the Form 13F-HR reports Twin Securities, Inc. files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.